The role of late-onset autoimmune diabetes in white familial NIDDM pedigrees

Diabetes Care

Volumn 20, Issue 8, 1997, Pages 1248-1251

  Elbein, Steven C ^a,b,d   Wegner, Kimberley ^a,b   Miles, Cindy ^a   Yu, Liping ^c   Eisenbarth, George ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d Special Treatment Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNITY; CAUCASIAN; GLUCOSE TOLERANCE TEST; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE;

EID: 0030856505     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.8.1248     Document Type: Article

References (15)

1. Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J: Shared genetic susceptibility of type I (insulin-dependent) and type 2 (non-insulin dependent) diabetes mellitus: contributions of HLA and haptoglobin. Diabetologia 34:350-355, 1991
2. Leslie RDG, Pozzilli P: Type I diabetes masquerading as type II diabetes. Diabetes Care 17:1214-1219, 1994
3. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
4. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 18:1557-1565, 1995
5. Davies JL, Yoshihiko K, Bennett S, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins C, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
6. Hashimoto L, Habita C, Beressi JP, Delephine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161-164, 1994
7. Field LL, Tobias R, Magnus T: A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet 8:189-194, 1994
8. Luo D, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nistico L, Giovannini C, Pozzilli P, Thomson G, She J: Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5, and IDDM8. Hum Mol Genet 5:693-698, 1996
9. Elbein SC, Hoffman MD, Mayorga RA, Barrett KL, Leppert M, Hasstedt S: Do non-insulin-dependent diabetes mellitus (NIDDM) and insulin-dependent diabetes mellitus (IDDM) share genetic susceptibility loci? An analysis of putative IDDM susceptibility regions in familial NIDDM. Metabolism 46:48-52, 1997
10. Tuomilehto Wolf E, Tuomilehto J, Hitman G, Nissinen A, Stengard J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen MJ: Genetic-susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in the HLA region. BMJ 307: 155-159, 1993
11. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shephard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Ommoi Y, Petzold C, Rietzsch H, Schroeder H-E, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Linder T, Mereu LE, Wang Y-Q, Xiang K, Yamagata K, Yang Y, Bell GI: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161-166, 1996
12. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka K, Rawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330:962-968, 1994
13. Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth G: Anti-islet antibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 82:375-380, 1997
14. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G: β-cell function in relation to islet cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902-910, 1993
15. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622-626, 1996